Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

• Publication date: December 2011

Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData’s new report, “Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global insulin pumps market. The report provides market landscape, competitive landscape and market trends information on the insulin pumps market. The...

Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData’s new report, “Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global insulin pumps market. The report provides market landscape, competitive landscape and market trends information on the insulin pumps market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Disposable Insulin Pumps and Traditional Insulin Pumps.
- Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints within the insulin pumps market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Animas Corporation and Insulet Corporation.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the insulin pumps globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What’s the next big thing in the insulin pumps market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global insulin pumps market and the factors shaping it.

Global Medical Equipment And Supply Industry

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction and Overview 7
2.1 Introduction 7
2.2 GlobalData Report Guidance 7
3 Disease Overview - Diabetes 8
3.1 Types of Diabetes 8
3.1.1 Type 1 diabetes 8
3.1.2 Type 2 diabetes 8
3.1.3 Gestational diabetes 8
3.2 Signs and Symptoms 8
3.3 Diagnosis 9
3.3.1 Fasting Plasma Glucose (FPG) Test 9
3.3.2 Oral Glucose Tolerance Test (OGTT) 9
3.3.3 Random Plasma Glucose Test 10
3.4 Epidemiology 10
3.4.1 Epidemiology of Diabetes in the US 11
3.4.2 Epidemiology of Diabetes in UK 11
3.4.3 Epidemiology of Diabetes in Japan 11
3.4.4 Epidemiology of Diabetes in India 11
3.4.5 Epidemiology of Diabetes in China 11
4 Insulin Pumps - Device Overview 12
4.1 Insulin Pumps, Market Segmentation 12
4.1.1 Traditional Insulin Pumps 12
4.1.2 Disposable Insulin Pumps 12
4.2 Comparison of Insulin Pumps with Other Insulin Delivery Devices 13
5 Insulin Pumps - Global Market Characterization 14
5.1 Insulin Pumps Market, Global, Revenue ($m), Historic, 2003–2010 14
5.2 Insulin Pumps Market, Global, Revenue ($m), Forecast, 2010–2017 15
5.3 Global Insulin Pumps Market, Key Trends 16
5.3.1 The US has a Higher Market Penetration Rate for Insulin Pumps Compared to Europe 16
5.3.2 FDA Plans to Tighten the Regulation of Infusion Pumps 16
5.3.3 Co-Marketing of Insulin Pumps with Blood Glucose Monitoring/Continuous Glucose Monitor Devices is a Recent Trend in the Market 17
5.3.4 Artificial Pancreas to be a Future Trend in the Insulin Pumps Market 17
5.4 Global Insulin Pumps, Market Dynamics 20
5.4.1 Market Drivers 20
5.4.2 Market Restraints 25
6 Global Insulin Pumps Market - Analysis by Segment 27
6.1 Traditional Insulin Pumps, Global, Revenue ($m), Historic, 2003?2010 27
6.2 Traditional Insulin Pumps, Global, Revenue ($m), Forecast, 2010?2017 28
6.2.1 Market Drivers 28
6.2.2 Market Restraints 29
6.3 Disposable Insulin Pumps, Global, Revenue ($m), Historic, 2005?2010 33
6.4 Disposable Insulin Pumps, Global, Revenue ($m), Forecast, 2010?2017 34
6.4.1 Market Drivers 35
6.4.2 Market Restraints 35
7 Global Insulin Pumps Market - Analysis and Forecasts by Country 36
7.1 Insulin Pumps Market, The US, Revenue ($m), Historic, 2003–2010 36
7.2 Insulin Pumps Market, The US, Revenue ($m), Forecast, 2010–2017 37
7.3 Insulin Pumps Market, Canada, Revenue ($m), Historic, 2003–2010 38
7.4 Insulin Pumps Market, Canada, Revenue ($m), Forecast, 2010–2017 39
7.5 Insulin Pumps Market, The UK, Revenue ($m), Historic, 2003–2010 40
7.6 Insulin Pumps Market, The UK, Revenue ($m), Forecast, 2010–2017 41
7.7 Insulin Pumps Market, Germany, Revenue ($m), Historic, 2003–2010 42
7.8 Insulin Pumps Market, Germany, Revenue ($m), Forecast, 2010–2017 43
7.9 Insulin Pumps Market, France, Revenue ($m), Historic, 2003–2010 44
7.10 Insulin Pumps Market, France, Revenue ($m), Forecast, 2010–2017 45
7.11 Insulin Pumps Market, Italy, Revenue ($m), Historic, 2003–2010 46
7.12 Insulin Pumps Market, Italy, Revenue ($m), Forecast, 2010–2017 47
7.13 Insulin Pumps Market, Spain, Revenue ($m), Historic, 2003–2010 48
7.14 Insulin Pumps Market, Spain, Revenue ($m), Forecast, 2010–2017 49
7.15 Insulin Pumps Market, Japan, Revenue ($m), Historic, 2003–2010 50
7.16 Insulin Pumps Market, Japan, Revenue ($m), Forecast, 2010–2017 51
7.17 Insulin Pumps Market, China, Revenue ($m), Historic, 2003–2010 52
7.18 Insulin Pumps Market, China, Revenue ($m), Forecast, 2010–2017 53
7.19 Insulin Pumps Market, India, Revenue ($m), Historic, 2003–2010 54
7.20 Insulin Pumps Market, India, Revenue ($m), Forecast, 2010–2017 55
7.21 Insulin Pumps Market, Australia, Revenue ($m), Historic, 2003–2010 56
7.22 Insulin Pumps Market, Australia, Revenue ($m), Forecast, 2010–2017 57
7.23 Insulin Pumps Market, Brazil, Revenue ($m), Historic, 2003–2010 58
7.24 Insulin Pumps Market, Brazil, Revenue ($m), Forecast, 2010–2017 59
8 Global Insulin Pumps Market - Competitive Assessment 60
8.1 Insulin Pumps Market, Global, Key Company Shares (%), 2010 60
8.2 Insulin Pumps Market, Global, Key Market Participants 61
8.2.1 Medtronic Inc. 61
8.2.2 Insulet Corporation 64
8.2.3 Roche (Disetronic Medical Systems AG) 67
8.2.4 Animas Corporation 68
9 Insulin Pumps - Pipeline Assessment 70
9.1 Insulin Pumps, Pipeline by Phase of Development, 2011 70
9.2 Pipeline Assessment by Developmental Stage, 2011 71
9.3 Key Pipeline Products 74
9.3.1 Artificial Pancreas System (Boston University) 74
9.3.2 Artificial Pancreas System (University of Virginia) 77
9.3.3 Cellnovo Wireless Insulin Pump System (Cellnovo Ltd.) 78
9.3.4 Eros Insulin Pump (Insulet Corporation) 78
9.3.5 Jewel Pump (Debiotech S.A.) 79
9.3.6 Minimed Model 2007 Implantable Insulin Pump (Medtronic, Inc.) 79
9.3.7 Paradigm Veo System (Medtronic, Inc.) 79
9.3.8 Solo MicroPump Insulin Delivery System (Roche Diagnostics GmbH) 80
10 Global Insulin Pumps Market - Strategic Deals Analysis 81
10.1 Key Deals, Insulin Pumps Market 81
10.1.1 Cellnovo Enters Into Technology Integration Agreement with LifeScan 81
10.1.2 Insulet Announced Acquisition of Neighborhood Diabetes 81
10.1.3 Insulet Entered into Distribution Agreement with GlaxoSmithKline 82
10.1.4 Cellnovo Entered into an Agreement with Home Diagnostics 82
10.1.5 Roche Holding Acquired Medingo from Elron Electronic Industries 82
10.1.6 JDRF Enters into an Agreement with Becton, Dickinson and Company 82
10.1.7 Insulet Enters into Distribution Agreement with Ypsomed Holding 83
11 Appendix 84
11.1 Market Definitions 85
11.1.1 Insulin Pumps 85
11.2 Abbreviations (in alphabetical order) 85
11.3 Sources 86
11.4 Research Methodology 86
11.5 GlobalData Consulting 88
11.6 Contact Us 88
11.7 Disclaimer 88

List of Tables

Table 1: Fasting Plasma Glucose Test 9
Table 2: Oral Glucose Tolerance Test 9
Table 3: Oral Glucose Tolerance Test for Gestational Diabetes 9
Table 4: Diabetes Prevalence (%) and Patient Population, by Country, 2011 10
Table 5: Insulin Pumps Market, Global, Revenue ($m), 2003–2010 14
Table 6: Insulin Pumps Market, Global, Revenue ($m), 2010–2017 15
Table 7: Organizations/Companies Developing Artificial Pancreas 18
Table 8: Annual Increase in the Incidence of Diabetes Among Children in Europe, 1983-2005 20
Table 9: Studies Indicating Safety and Efficacy of Insulin Pumps 22
Table 10: Studies Indicating Safety and Efficacy of Insulin Pump Therapy in Pregnant Women, 2001-2011 23
Table 11: Studies Suggesting Higher Risk of Ketoacidosis from Insulin Pump Use, 2004 & 2009 25
Table 12: Traditional Insulin Pumps, Global, Revenue ($m), 2003?2010 27
Table 13: Traditional Insulin Pumps, Global, Revenue ($m), 2010?2017 28
Table 14: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income <$15000, June 2011 29
Table 15: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $43,000, June 2011 30
Table 16: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $75,000, June 2011 31
Table 17: Disposable Insulin Pumps, Global, Revenue ($m), 2005?2010 33
Table 18: Disposable Insulin Pumps, Global, Revenue ($m), 2010?2017 34
Table 19: Insulin Pumps Market, The US, Revenue ($m), 2003–2010 36
Table 20: Insulin Pumps Market, The US, Revenue ($m), 2010–2017 37
Table 21: Insulin Pumps Market, Canada, Revenue ($m), 2003–2010 38
Table 22: Insulin Pumps Market, Canada, Revenue ($m), 2010–2017 39
Table 23: Insulin Pumps Market, The UK, Revenue ($m), 2003–2010 40
Table 24: Insulin Pumps Market, The UK, Revenue ($m), 2010–2017 41
Table 25: Insulin Pumps Market, Germany, Revenue ($m), 2003–2010 42
Table 26: Insulin Pumps Market, Germany, Revenue ($m), 2010–2017 43
Table 27: Insulin Pumps Market, France, Revenue ($m), 2003–2010 44
Table 28: Insulin Pumps Market, France, Revenue ($m), 2010–2017 45
Table 29: Insulin Pumps Market, Italy, Revenue ($m), 2003–2010 46
Table 30: Insulin Pumps Market, Italy, Revenue ($m), 2010–2017 47
Table 31: Insulin Pumps Market, Spain, Revenue ($m), 2003–2010 48
Table 32: Insulin Pumps Market, Spain, Revenue ($m), 2010–2017 49
Table 33: Insulin Pumps Market, Japan, Revenue ($m), 2003–2010 50
Table 34: Insulin Pumps Market, Japan, Revenue ($m), 2010–2017 51
Table 35: Insulin Pumps Market, China, Revenue ($m), 2003–2010 52
Table 36: Insulin Pumps Market, China, Revenue ($m), 2010–2017 53
Table 37: Insulin Pumps Market, India, Revenue ($m), 2003–2010 54
Table 38: Insulin Pumps Market, India, Revenue ($m), 2010–2017 55
Table 39: Insulin Pumps Market, Australia, Revenue ($m), 2003–2010 56
Table 40: Insulin Pumps Market, Australia, Revenue ($m), 2010–2017 57
Table 41: Insulin Pumps Market, Brazil, Revenue ($m), 2003–2010 58
Table 42: Insulin Pumps Market, Brazil, Revenue ($m), 2010–2017 59
Table 43: Insulin Pumps Market, Global, Key Company Revenues ($m), 2010 60
Table 44: Pipeline Products, Medtronic Inc. 63
Table 45: Key Products, Medtronic Inc. 64
Table 46: Key Products, Insulet Corporation 66
Table 47: Key Products, Disetronic Medical Systems AG 67
Table 48: Pipeline Products, Animas Corporation 68
Table 49: Key Products, Animas Corporation 69
Table 50: Insulin Pumps, Pipeline by Phase of Development, 2011 70
Table 51: Pipeline Products, Insulin Pumps 72
Table 52: Artificial Pancreas System (Boston University), Clinical Trial Details 74
Table 53: Artificial Pancreas System (University of Virginia), Clinical Trial Details 77
Table 54: Key Deals, Insulin Pumps Market, 2009-2011 81

1.2 List of Figures

Figure 1: Diabetes Prevalence (%), Global, 2011 10
Figure 2: Insulin Pumps, Market Segmentation 12
Figure 3: Comparison of Insulin Pumps with Other Insulin Delivery Devices 13
Figure 4: Insulin Pumps Market, Global, Revenue ($m), 2003–2010 14
Figure 5: Insulin Pumps Market, Global, Revenue ($m), 2010–2017 15
Figure 6: Working of Artificial Pancreas 17
Figure 7: Global Insulin Pumps, Market Dynamics 20
Figure 8: Reasons for Type 1 Diabetes in Children 21
Figure 9: Traditional Insulin Pumps, Global, Revenue ($m), 2003?2010 27
Figure 10: Traditional Insulin Pumps, Global, Revenue ($m), 2010?2017 28
Figure 11: Individual Out-of-Pocket Expenses for Diabetes Management in Canadian Provinces with Annual Income <$15,000, June 2011 29
Figure 12: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $43,000, June 2011 30
Figure 13: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $75,000, June 2011 31
Figure 14: Disposable Insulin Pumps, Global, Revenue ($m), 2005?2010 33
Figure 15: Disposable Insulin Pumps, Global, Revenue ($m), 2010?2017 34
Figure 16: Insulin Pumps Market, The US, Revenue ($m), 2003–2010 36
Figure 17: Insulin Pumps Market, The US, Revenue ($m), 2010–2017 37
Figure 18: Insulin Pumps Market, Canada, Revenue ($m), 2003–2010 38
Figure 19: Insulin Pumps Market, Canada, Revenue ($m), 2010–2017 39
Figure 20: Insulin Pumps Market, The UK, Revenue ($m), 2003–2010 40
Figure 21: Insulin Pumps Market, The UK, Revenue ($m), 2010–2017 41
Figure 22: Insulin Pumps Market, Germany, Revenue ($m), 2003–2010 42
Figure 23: Insulin Pumps Market, Germany, Revenue ($m), 2010–2017 43
Figure 24: Insulin Pumps Market, France, Revenue ($m), 2003–2010 44
Figure 25: Insulin Pumps Market, France, Revenue ($m), 2010–2017 45
Figure 26: Insulin Pumps Market, Italy, Revenue ($m), 2003–2010 46
Figure 27: Insulin Pumps Market, Italy, Revenue ($m), 2010–2017 47
Figure 28: Insulin Pumps Market, Spain, Revenue ($m), 2003–2010 48
Figure 29: Insulin Pumps Market, Spain, Revenue ($m), 2010–2017 49
Figure 30: Insulin Pumps Market, Japan, Revenue ($m), 2003–2010 50
Figure 31: Insulin Pumps Market, Japan, Revenue ($m), 2010–2017 51
Figure 32: Insulin Pumps Market, China, Revenue ($m), 2003–2010 52
Figure 33: Insulin Pumps Market, China, Revenue ($m), 2010–2017 53
Figure 34: Insulin Pumps Market, India, Revenue ($m), 2003–2010 54
Figure 35: Insulin Pumps Market, India, Revenue ($m), 2010–2017 55
Figure 36: Insulin Pumps Market, Australia, Revenue ($m), 2003–2010 56
Figure 37: Insulin Pumps Market, Australia, Revenue ($m), 2010–2017 57
Figure 38: Insulin Pumps Market, Brazil, Revenue ($m), 2003–2010 58
Figure 39: Insulin Pumps Market, Brazil, Revenue ($m), 2010–2017 59
Figure 40: Insulin Pumps Market, Global, Key Company Shares (%), 2010 60
Figure 41: Insulin Pumps Market, Competitive Assessment 61
Figure 42: Insulin Pumps, Pipeline by Phase of Development, 2011 70
Figure 43: Pipeline Assessment by Developmental Stage, 2011 71

Companies mentioned
Medtronic Inc.
Insulet Corporation
Roche (Disetronic Medical Systems AG)
Animas Corporation